S1 GLP
Description
Semaglutide is a long-acting, synthetic peptide analog of human glucagon-like peptide-1 (GLP-1).
Available in 2mg–50mg vials, every lot is third-party tested for identity and purity, with certificates of analysis available on request. Vials arrive sealed and sterile, lyophilized for stability, and ship from our U.S. facility in 2–6 days.
For in vitro laboratory research use only. See the Technical Data tab below for the full mechanism and feature summary.
S1 GLP from Wolf Research is a high-purity research-grade compound intended strictly for laboratory research use.
S1 GLP (Semaglutide (GLP-1 receptor agonist)) is supplied as a research-grade compound for in vitro study of incretin and metabolic receptor signaling pathways. GLP-class research compounds are widely used in laboratory studies of glucose metabolism, appetite-related pathways, and receptor pharmacology.
Every lot of S1 GLP is third-party tested for identity and purity, with certificates of analysis available on request. Supplied in sealed, sterile vials and shipped fast from our U.S. facility.
The products offered herein are intended exclusively for research purposes and must be utilized solely within in vitro environments (e.g., test tubes or laboratory settings) for the purposes of testing and experimentation. All information provided on this website is strictly for educational purposes and does not constitute legal or professional advice. It is imperative to acknowledge that the introduction of these products into humans or animals, in any capacity, is strictly prohibited by applicable laws and regulations. Violation of these regulations may result in legal repercussions. These products are intended solely for use by qualified, licensed professionals with the expertise to handle them safely and responsibly. Furthermore, it is important to note that these products are not classified as drugs, food, or cosmetics under any legal definitions. Any misbranding, misuse, or mislabeling of these products within these categories is expressly prohibited and may lead to further legal consequences. By adhering to these guidelines, you ensure compliance with all regulatory frameworks and contribute to the responsible conduct of scientific research.
Technical Data
| Semaglutide is a long-acting, synthetic peptide analog of human glucagon-like peptide-1 (GLP-1). Featuring key structural modifications—including an amino acid substitution at position 8 and a C-18 fatty acid diacid chain attachment—Semaglutide exhibits extended half-life and enhanced resistance to dipeptidyl peptidase-4 (DPP-4) enzymatic degradation. High-purity Semaglutide provides researchers with an optimized tool for investigating metabolic signaling pathways, insulinotropic activity, and receptor-binding dynamics in laboratory cell cultures and tissue models. | |
|---|---|
| Primary Research Applications | |
| GLP-1 Receptor Kinetics | Evaluating binding affinity, intracellular signaling cascades, and receptor endocytosis in cell lines. |
| Metabolic & Glycemic Signaling | Investigating insulin secretion mechanisms, glucagon suppression, and glucose-dependent cellular pathways in vitro. |
| Satiety & Neuroendocrine Studies | Studying central nervous system peptide signaling and microenvironment nutrient-sensing mechanisms. |